How does the 2025 IPPS Proposed Rule impact IPPS, CAR-T therapy & stem cell transplant? Join us tomorrow at 12 PM CT for a webinar on all updates & changes introduced by the new rule. Learn more & register: ow.ly/pGbo50RGmK1

In this episode of ASTCT Talks Rebecca Epperly MD & Aimee Talleur of St. Jude Research, dive into the pioneering realm of #CARTcells therapy & its late effects on pediatric patients. Listen now on Nucleus or wherever you get podcasts: ow.ly/6aK950RrmjT #celltherapy

Evidence suggests conditioning with CD45-targeted antibody-drug-conjugates (CD45-ADC) may benefit patients with Fanconi anemia (FA) who undergo #alloHSCT . Read more on Nucleus: ow.ly/hgwg50RzWSP Blood Journal

In this upcoming webinar, the ASTCT Palliative Care special interest group will review the evidence base on palliative care for improving #HCT and cell therapy patient outcome and how to best integrate them into practice. Register now: ow.ly/RBuS50RzTRb

How does the 2025 IPPS Proposed Rule impact IPPS, CAR-T therapy & stem cell transplant? ASTCT’s government relations director & policy consultants will be covering all updates & changes introduced by the new rule next Wednesday, May 15 at 12 p.m. CT. ow.ly/tnkv50RzQNS

#GVHD Alliance member, The Leukemia & Lymphoma Society is presenting a free webinar on living with #GVHD , which will feature transplant experts and patient advocate, Meredith Cowden. Share with your patients or community for them to attend on May 22, 5 PM CT: ow.ly/xH3u50RzRzB

We'd like to take a moment this #NursesWeek to recognize and celebrate the dedicated hematopoietic cell transplantation and cell therapy nurses who work tirelessly day and night to provide care for their patients. Thank you 💙 #NursesMaketheDifference #NationalNursesWeek

Leaving ASTCT Leadership Course where we bring new/emerging leaders in #BMT #CellTherapy and discuss foundational aspects of healthcare leadership. 🙏 to faculty/participants + co-chairs Dianna S Howard Dr Cook for sharing their experiences and insights. Future of our field is 👍

Thank you to everyone who attended the 2024 Leadership Course with leaders in the #HCT and #CellularTherapy field. Here we like to amplify diversity, mentorship, sponsorship and build connections to invest in the future of ASTCT!

Day 2 of the ASTCT’s Leadership Course is underway! 15 emerging #HCT and cell therapy leaders have the opportunity to gain coaching & career advice from esteemed professionals in the field. ow.ly/HZ6R50RvUee

The 3rd Joint #SciMeeting24 with ASTCT is around the corner! Explore cutting-edge basic and translational #biology in the field, and discover the forefront of #HCT and #CellularTherapy ! 🔬🧬 Don't miss out, see you in 📍 Washington, D.C. ⬇️
ebmt.org/events/3rd-joi…

Join us on May 8 for the Pharmacy #HCT Core Topics live session on immunosuppression management and HCT complications. Register for free: ow.ly/TV6W50RlFry

Researchers discovered a significant function of Id3 protein in persistence & operational capabilities of tissue-infiltrating alloreactive T cells, offering insights that could impact #GVHD treatment & #CARTcell therapy effectiveness: ow.ly/r86850RencB #Nucleus

In this episode of ASTCT Talks Rebecca Epperly MD & Aimee Talleur of St. Jude Research, dive into the pioneering realm of #CARTcells therapy & its late effects on pediatric patients. Listen now on Nucleus or wherever you get podcasts: ow.ly/6aK950RrmjT #celltherapy

With #HCT procedures on the rise, it's crucial to address long-term complications. This review provides updated pediatric and adult survivorship guidelines for #HCT and cellular therapy. Read more: ow.ly/3zxh50Rr2oQ

Search cell therapy and transplantation education and sort resources by topics such as #CARTcells , #GVHD , #HCT and more in the newly redesigned ASTCT Learning Center. Browse education now: learn.astct.org